Eric Evangelista

Background

About Eric Evangelista

Eric N. Evangelista is a Master's of Public Health (MPH) candiate at the Rollins School of Public Health at Emory University. Most recently, Mr. Evangelista worked as a Human Resources Coordinator for the law firm of White and Williams LLP in Philadelphia. He also worked as a Paralegal at The Wistar Institute, a world-renowned biomedical and scientific research institution, with focuses on oncology, immunology, infectious disease and vaccine research. At Wistar, Mr. Evangelista provided direct support to the Office of General Counsel, and specialized in local, state, and federal government affairs. Mr. Evangelista previously worked as a Healthcare Communications Specialist at Ashfield Healthcare, LLC, assisting Moderna in the nationwide rollout of their COVID-19 vaccine. Prior to his tenure at Ashfield Healthcare, LLC, Mr. Evangelista served as an Office Adminstration Project Assistant for the internationally renowned law firm Skadden, Arps, Slate, Meagher & Flom LLP. As a student, Mr. Evangelista was a Research Intern for the Hudson Institute's Center for Political-Military Analysis, a Legislative Intern in the United States Senate in Washington, DC, and as a Congressional Intern in the U.S. House of Representatives in New York's 24th Congressional District. He has also perviously worked as an Administrative Assistant for the Office of Clinical Legal Education at the Syracuse University College of Law. Mr. Evangelista is a graduate of Syracuse University, where he studied Political Science and minored in History. At Syracuse, Mr. Evangelista served as Student Body President, Phi Alpha Delta Law Fraternity, and Alpha Phi Omega. Mr. Evangelista also served as a University 100 Campus Ambassador, President of the International Relations Club, an Undergraduate Representative to the University's Board of Trustees, and a voting member of the Syracuse University Alumni Association Board of Directors. Mr. Evangelista presently dedicates his spare time to raising much-needed awareness and funds for Alzheimer’s disease.